564 related articles for article (PubMed ID: 17301289)
1. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking.
Wieman HL; Wofford JA; Rathmell JC
Mol Biol Cell; 2007 Apr; 18(4):1437-46. PubMed ID: 17301289
[TBL] [Abstract][Full Text] [Related]
2. A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression.
Buller CL; Loberg RD; Fan MH; Zhu Q; Park JL; Vesely E; Inoki K; Guan KL; Brosius FC
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C836-43. PubMed ID: 18650261
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
4. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface.
Bentley J; Itchayanan D; Barnes K; McIntosh E; Tang X; Downes CP; Holman GD; Whetton AD; Owen-Lynch PJ; Baldwin SA
J Biol Chem; 2003 Oct; 278(41):39337-48. PubMed ID: 12869574
[TBL] [Abstract][Full Text] [Related]
6. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake.
Edinger AL; Thompson CB
Mol Biol Cell; 2002 Jul; 13(7):2276-88. PubMed ID: 12134068
[TBL] [Abstract][Full Text] [Related]
7. Cytokine stimulation promotes increased glucose uptake via translocation at the plasma membrane of GLUT1 in HEK293 cells.
Zambrano A; Jara E; Murgas P; Jara C; Castro MA; Angulo C; Concha II
J Cell Biochem; 2010 Aug; 110(6):1471-80. PubMed ID: 20506349
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein.
Hong SY; Yu FX; Luo Y; Hagen T
Cell Signal; 2016 May; 28(5):377-383. PubMed ID: 26826652
[TBL] [Abstract][Full Text] [Related]
9. Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation.
Barnes K; McIntosh E; Whetton AD; Daley GQ; Bentley J; Baldwin SA
Oncogene; 2005 May; 24(20):3257-67. PubMed ID: 15735728
[TBL] [Abstract][Full Text] [Related]
10. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival.
Rathmell JC; Fox CJ; Plas DR; Hammerman PS; Cinalli RM; Thompson CB
Mol Cell Biol; 2003 Oct; 23(20):7315-28. PubMed ID: 14517300
[TBL] [Abstract][Full Text] [Related]
11. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
Liu Y; Zhao Y; Guo L
Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
[TBL] [Abstract][Full Text] [Related]
12. Galectin-1 upregulates glucose transporter-1 expression level via protein kinase C, phosphoinositol-3 kinase, and mammalian target of rapamycin pathways in mouse embryonic stem cells.
Lee MY; Han HJ
Int J Biochem Cell Biol; 2008; 40(11):2421-30. PubMed ID: 18479958
[TBL] [Abstract][Full Text] [Related]
13. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.
Tzatsos A; Kandror KV
Mol Cell Biol; 2006 Jan; 26(1):63-76. PubMed ID: 16354680
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic Akt activation on glucose uptake in the heart.
Matsui T; Nagoshi T; Hong EG; Luptak I; Hartil K; Li L; Gorovits N; Charron MJ; Kim JK; Tian R; Rosenzweig A
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E789-97. PubMed ID: 16352665
[TBL] [Abstract][Full Text] [Related]
15. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
[TBL] [Abstract][Full Text] [Related]
16. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
17. IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1.
Sommermann TG; O'Neill K; Plas DR; Cahir-McFarland E
Cancer Res; 2011 Dec; 71(23):7291-300. PubMed ID: 21987722
[TBL] [Abstract][Full Text] [Related]
18. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
19. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways.
Jacobs SR; Herman CE; Maciver NJ; Wofford JA; Wieman HL; Hammen JJ; Rathmell JC
J Immunol; 2008 Apr; 180(7):4476-86. PubMed ID: 18354169
[TBL] [Abstract][Full Text] [Related]
20. Glucose uptake in brown fat cells is dependent on mTOR complex 2-promoted GLUT1 translocation.
Olsen JM; Sato M; Dallner OS; Sandström AL; Pisani DF; Chambard JC; Amri EZ; Hutchinson DS; Bengtsson T
J Cell Biol; 2014 Nov; 207(3):365-74. PubMed ID: 25385184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
